FREE NEJM E-TOC    HOME   |   SUBSCRIBE   |   CURRENT ISSUE   |   PAST ISSUES   |   COLLECTIONS   |   Search Term  Advanced Search

Sign in | Get NEJM's E-Mail Table of Contents — Free | Subscribe

Previous Volume 337:1629-1630 November 27, 1997 Number 22 Next

	Since this article has no abstract, we have provided an extract of the first 100 words of the full text and any section headings.

	Full Text Purchase this article Add to Personal Archive Add to Citation Manager Notify a Friend E-mail When Cited Related Article by Laskin, C. A. PubMed Citation

To the Editor: We applaud Laskin et al. (July 17 issue)¹ for completing a large trial of prednisone and aspirin in women with autoantibodies and unexplained recurrent fetal loss. We believe, however, that several aspects of the study deserve comment.

First, 22 percent of the women had had only two pregnancy losses and therefore did not meet the traditional criteria (three or more pregnancy losses, with no more than one live birth) for the diagnosis of recurrent pregnancy loss. In addition, the women had a mixture of preembryonic, embryonic, and fetal losses. It is also unclear whether all the women . . . [Full Text of this Article]

References

HOME  |  SUBSCRIBE  |  SEARCH  |  CURRENT ISSUE  |  PAST ISSUES  |  COLLECTIONS  |  PRIVACY  |  HELP  |  beta.nejm.org Comments and questions? Please contact us. The New England Journal of Medicine is owned, published, and copyrighted © 2008 Massachusetts Medical Society. All rights reserved.